Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cellular membrane phospholipid bilayer is the fundamental structural matrix of all biological membranes, consisting of two layers of amphiphilic phospholipids with hydrophobic tails and hydrophilic heads (StatPearls, NBK555964). It serves as a critical semi-permeable barrier that maintains cellular homeostasis by regulating the transport of ions and molecules (NIH, Cell Membrane). In therapeutic contexts, the lipid bilayer is a primary target for several classes of anti-infective agents, such as polyene antifungals and lipopeptide antibiotics, which act by disrupting membrane integrity or forming lethal pores (PubMed, PMID: 25108313). Additionally, the composition and fluidity of the bilayer influence the function of embedded receptors and transporters, making it a site of action for various anesthetics and signaling modulators (PubMed, PMID: 18482075). Pathological changes in membrane lipid composition are associated with diseases like cancer and neurodegeneration, where altered membrane dynamics can drive disease progression (PubMed, PMID: 27039031).
Drugs targeting the lipid bilayer typically act through physical disruption of the membrane structure. This includes the formation of transmembrane pores (e.g., polyenes), detergent-like solubilization (e.g., polymyxins), or calcium-dependent insertion leading to rapid depolarization (e.g., daptomycin) (PubMed, PMID: 25108313). Some agents also alter membrane fluidity or thickness, indirectly modulating the activity of membrane-bound proteins (PubMed, PMID: 18482075).
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular membrane phospholipid bilayer.